Clin2
NCT07373457Likely a fitRecruiting

Testing a new drug in healthy volunteers

Healthy ParticipantsIBD (Inflammatory Bowel Disease)

Part of Digestive system clinical trials.

This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
104 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good general health with no major medical conditions.
  • You weigh at least 50 kg (110 lbs) if male, or at least 45 kg (99 lbs) if female, with a BMI between 18 and 28.
  • You are willing to use effective birth control for at least 6 months after the last dose.
  • You have not smoked more than 5 cigarettes a day in the last 3 months.
  • You have not taken any other experimental drugs in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07632573Recruiting· Phase 1
Safety Study of BDHK-2009 Tablets in Healthy Adults

This is an early-stage safety study testing a new experimental tablet called BDHK-2009 in healthy volunteers with no major illnesses. Researchers want to make sure the drug is safe and well-tolerated before testing it in people with medical conditions.

Hangzhou, Zhejiang
NCT06897813Not yet recruiting· Phase 1
Safety study of a new drug in healthy adults

This early-stage study tests a new investigational drug (called WD-910) in healthy volunteers to see how safe it is, how the body processes it, and how it affects the body. You would receive either the drug or a placebo (a pill with no active medicine), and doctors will monitor you closely.

Melbourne, Victoria
NCT07448155Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.

Tempe, Arizona
NCT07799597Not yet recruiting· Phase 1
Testing a new capsule in healthy adults

This study tests a new medicine called HBW-3220 in healthy adults to see how the body processes it and whether food affects it. Participants will take the capsule and have blood samples taken to measure the medicine's levels.

NCT07869225Not yet recruiting· Phase 1
Healthy volunteer study of a new test drug (EQ504)

This early-stage study tests a new drug called EQ504 in healthy volunteers to see how safe it is and how the body handles it. Participants receive either the drug or a placebo (inactive substance), and the study helps determine the right dose for future research.

Melbourne
NCT07448194Recruiting· Phase 1
Safety study of HW241045 in healthy adults

This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.

Beijing

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.